Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Quality Index
Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Quality Index of 2.86x as of December 2023. Operating cash flow of $13.55 Million exceeds net income of $4.73 Million, indicating high earnings quality where cash backs reported profits. Also explore Amylyx Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Amylyx Pharmaceuticals Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Amylyx Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AMLX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year earnings quality comparison for Amylyx Pharmaceuticals Inc. For live market cap and the full company financial profile, see AMLX market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | $11.92 Million | $49.27 Million | — |